{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-071658","form_type":"8-K","ticker":"PRPO","cik":"0001043961","company_name":"Precipio, Inc.","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.747321+00:00","generated_at":"2026-06-13T23:36:58.071840+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Precipio shareholders elect directors, ratify auditor, authorize reverse stock split up to 1:30","bullets":["Elected Richard Sandberg, Douglas Fisher, Jeffrey Cossman as Class II directors (terms expiring 2026); each received >5.2M votes for.","Ratified Marcum LLP as independent auditor for FY 2023 with 11.29M for, 0.53M against.","Approved board authorization to effect reverse stock split (ratio 1:2 to 1:30) and proportionally reduce authorized shares; 7.84M for, 3.90M against.","Quorum of 11.92M shares (50.86%) present at June 15, 2023 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-071658","json":"https://secwatch.observer/filing/0001104659-23-071658.json","markdown":"https://secwatch.observer/filing/0001104659-23-071658.md","text":"https://secwatch.observer/filing/0001104659-23-071658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1043961/000110465923071658/0001104659-23-071658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1043961/000110465923071658/tm2318854d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:36:58.071840+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7bb7c0957c4617f1114454aa2114da1388c42918","claim":"Precipio, Inc. shareholders approved ratify the appointment of Marcum LLP as our independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-15 meeting.","evidence_excerpt":"Proposal 2: proposal to ratify the appointment of Marcum LLP as our independent registered public accounting firm for the year ending December 31, 2023 as set forth in the Proxy Statement, was as follows: Votes For Votes Against Abstentions Total Shares 11,289,762 527,918 103,769","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465923071658/0001104659-23-071658-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"95511ee1ec510879d3cc847a98d5ba0b79a61aed","claim":"Precipio, Inc. shareholders approved authorize the Company’s Board of Directors to, in its discretion, to amend the Company’s Third Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio not less than 1-for-2 and not greater than 1-for-30 at any time prior to the one-year anniversary of the date on at the 2023-06-15 meeting.","evidence_excerpt":"Proposal 3 : proposal to authorize the Company’s Board of Directors to, in its discretion, to amend the Company’s Third Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio not less than 1-for-2 and not greater than 1-for-30 at any time prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company’s stockholders at the Annual Meeting without further approval or authorization of our stockholders and with our Board of Directors able to elect to abandon such proposed amendment and not effect the reverse stock split authorized by stockholders, in its sole discretion, and, in connection therewith, to decrease the number of authorized shares of our common stock on a basis proportional to the reverse stock split ratio. Votes For Votes Against Abstain Total Shares Voted 7,837,960 3,899,731 183,758","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465923071658/0001104659-23-071658-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"efe763ca83e34712fdf5be4a9833d828d78348c5","claim":"Precipio, Inc. shareholders approved election of Richard Sandberg, Douglas Fisher, M.D. and Jeffrey Cossman, M.D. as Class II directors for terms to expire in 2026 at the 2023-06-15 meeting.","evidence_excerpt":"Proposal 1: proposal to elect Richard Sandberg, Douglas Fisher, M.D. and Jeffrey Cossman, M.D. as Class II directors for terms to expire in 2026: Votes For Votes Against Withheld Brokers Non-Votes Total Shares Voted 5,304,480 0 536,962 6,080,007 Richard Sandberg Votes For Votes Against Withheld Total Shares 5,233,264 0 608,178 Douglas Fisher M.D. Votes For Votes Against Withheld Total Shares 5,212,360 0 629,082 Jeffery Cossman M.D. Votes For Votes Against Withheld Total Shares 5,207,139 0 634,303","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465923071658/0001104659-23-071658-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}